Bill Text: FL S0888 | 2017 | Regular Session | Introduced

---

Bill Title: Prescription Drug Price Transparency

Spectrum: Partisan Bill (Republican 1-0)

Status: (Introduced - Dead) 2017-05-04 - Laid on Table, companion bill(s) passed, see HB 589 (Ch. 2017-86) [S0888 Detail]

Download: Florida-2017-S0888-Introduced.html

---

       Florida Senate - 2017                                     SB 888
       
       
        
       By Senator Bean
       
       
       
       
       
       4-01279-17                                             2017888__
    1                        A bill to be entitled                      
    2         An act relating to prescription drug price
    3         transparency; amending s. 408.062, F.S.; requiring the
    4         Agency for Health Care Administration to collect data
    5         on the retail prices charged by pharmacies for the 300
    6         most frequently prescribed medicines; requiring the
    7         agency to update its website monthly; providing an
    8         effective date.
    9          
   10  Be It Enacted by the Legislature of the State of Florida:
   11  
   12         Section 1. Paragraph (h) of subsection (1) of section
   13  408.062, Florida Statutes, is amended to read:
   14         408.062 Research, analyses, studies, and reports.—
   15         (1) The agency shall conduct research, analyses, and
   16  studies relating to health care costs and access to and quality
   17  of health care services as access and quality are affected by
   18  changes in health care costs. Such research, analyses, and
   19  studies shall include, but not be limited to:
   20         (h) The collection of a statistically valid sample of data
   21  on the retail prices charged by pharmacies for the 300 100 most
   22  frequently prescribed medicines from any pharmacy licensed by
   23  this state as a special study authorized by the Legislature to
   24  be performed by the agency quarterly. If the drug is available
   25  generically, price data shall be reported for the generic drug
   26  and price data of a brand-named drug for which the generic drug
   27  is the equivalent shall be reported. The agency shall make
   28  available on its Internet website for each pharmacy, no later
   29  than October 1, 2006, drug prices for a 30-day supply at a
   30  standard dose. The data collected shall be reported for each
   31  drug by pharmacy and by metropolitan statistical area or region
   32  and updated monthly quarterly.
   33         Section 2. This act shall take effect upon becoming a law.